Analystreport

ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

ZIOPHARM Oncology Inc  (ZIOP) 
Last ziopharm oncology inc earnings: 3/2 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ziopharm.com